DE60044674D1 - Verwendung von rhamnolipiden zur wundheilung, behaund periodontaler regeneration - Google Patents

Verwendung von rhamnolipiden zur wundheilung, behaund periodontaler regeneration

Info

Publication number
DE60044674D1
DE60044674D1 DE60044674T DE60044674T DE60044674D1 DE 60044674 D1 DE60044674 D1 DE 60044674D1 DE 60044674 T DE60044674 T DE 60044674T DE 60044674 T DE60044674 T DE 60044674T DE 60044674 D1 DE60044674 D1 DE 60044674D1
Authority
DE
Germany
Prior art keywords
wound healing
rhamnolipides
periodontal regeneration
epithelization
including periodontal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60044674T
Other languages
English (en)
Inventor
Tamara Stipcevic
Tihana Piljac
Jasenka Piljac
Tatjana Dujmic
Goran Piljac
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Paradigm Biomedical Inc
Original Assignee
Paradigm Biomedical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paradigm Biomedical Inc filed Critical Paradigm Biomedical Inc
Application granted granted Critical
Publication of DE60044674D1 publication Critical patent/DE60044674D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE60044674T 1999-08-05 2000-08-07 Verwendung von rhamnolipiden zur wundheilung, behaund periodontaler regeneration Expired - Lifetime DE60044674D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14726599P 1999-08-05 1999-08-05
PCT/US2000/017875 WO2001010447A1 (en) 1999-08-05 2000-08-07 Use of rhamnolipids in wound healing, treatment and prevention of gum disease and periodontal regeneration

Publications (1)

Publication Number Publication Date
DE60044674D1 true DE60044674D1 (de) 2010-08-26

Family

ID=22520899

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60044674T Expired - Lifetime DE60044674D1 (de) 1999-08-05 2000-08-07 Verwendung von rhamnolipiden zur wundheilung, behaund periodontaler regeneration

Country Status (7)

Country Link
US (1) US7129218B2 (de)
EP (1) EP1200100B1 (de)
AT (1) ATE473749T1 (de)
AU (1) AU6489300A (de)
CA (1) CA2378557C (de)
DE (1) DE60044674D1 (de)
WO (1) WO2001010447A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2660055A1 (fr) * 1990-03-26 1991-09-27 Serva Soc Dispositif de filtration et de stabilisation de pression pour installation de ventilation a debit variable.
CA2666674C (en) * 2006-10-17 2011-05-31 Idemitsu Kosan Co., Ltd. Feed additive and feed
EP2457567B1 (de) * 2007-09-19 2015-12-30 Nagoya Industrial Science Research Institute Wirkstoff mit Aktivität ähnlich des neurotrophen Faktors
US20090187484A1 (en) * 2008-01-18 2009-07-23 Cleareso, Llc Soil treatments with carbon dioxide
US20090186761A1 (en) * 2008-01-18 2009-07-23 Cleareso, Llc Use of bio-derived surfactants for mitigating damage to plants from pests
US20090186767A1 (en) * 2008-01-18 2009-07-23 Cleareso, Llc Use of surfactants for mitigating damage to plants from pests
US20100115833A1 (en) * 2008-11-10 2010-05-13 Green Knight Technologies, Llc Soil treatments with greenhouse gas
US8592381B2 (en) * 2008-12-18 2013-11-26 Rhamnopharma Inc. Method for treating rhinitis and sinusitis by rhamnolipids
BR112013014236B1 (pt) 2010-12-09 2021-03-30 Y&B Mother's Choice Ltd Composição cosmética ou de limpeza e produto de consumo
EP2648809B1 (de) 2010-12-09 2019-04-03 Y&B Mother's Choice Ltd. Natürliche formulierungen
US10434058B2 (en) 2010-12-09 2019-10-08 Y&B Mother's Choice Ltd. Natural formulations
EP2786742A1 (de) * 2013-04-02 2014-10-08 Evonik Industries AG Kosmetika enthaltend Rhamnolipide
DE102013205756A1 (de) * 2013-04-02 2014-10-02 Evonik Industries Ag Mischungszusammensetzung enthaltend Rhamnolipide
WO2015030702A2 (en) * 2013-08-26 2015-03-05 Keith Desanto High purity rhamnolipid cosmetic application
IL229836A0 (en) 2013-12-08 2014-03-31 Y & B Mother S Choice Ltd Formulations to reduce or suppress irritation to eye tissue
CN105326848A (zh) * 2015-11-26 2016-02-17 浙江大学 一种鼠李糖脂在制备抗纤维化药物制剂中的用途
EP3419985A1 (de) 2016-02-22 2019-01-02 Evonik Degussa GmbH Rhamnolipidester als nichtionische tenside zur kosmetischen anwendung
EP3579819A1 (de) 2017-02-10 2019-12-18 Evonik Operations GmbH Mundpflegezusammensetzung mit mindestens einem biotensid und fluorid
EP3672690A1 (de) 2017-08-24 2020-07-01 Evonik Operations GmbH Rhamnolipidderivate als emulgatoren und dispergierhilfsmittel
EP4185595A1 (de) 2020-07-22 2023-05-31 Evonik Operations GmbH Rhamnolipid-oligoester
EP4015588A1 (de) 2020-12-15 2022-06-22 Evonik Operations GmbH Verwendung von rhamnolipiden und/oder sophorolipiden in beschichtungszusammensetzungen zur erhaltung eines homogenen farbbildes des trockenen beschichtungsfilms und/oder zur erhöhung der arbeitssicherheit bei der herstellung von beschichtungszusammensetzungen
EP4015583A1 (de) 2020-12-15 2022-06-22 Evonik Operations GmbH Verwendung von rhamnolipiden und/oder sophorolipiden zur erhöhung der ergiebigkeit und/oder zur erhaltung der applikationseigenschaften bei lagerung von beschichtungszusammensetzungen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5254538A (en) * 1989-10-04 1993-10-19 Trustees Of Boston University Method of treating periodontal disease
US5652274A (en) * 1991-03-01 1997-07-29 Martin; Alain Therapeutic-wound healing compositions and methods for preparing and using same
US5466675A (en) * 1992-02-04 1995-11-14 Piljac; Goran Immunological activity of rhamnolipids
BE1005704A4 (nl) * 1992-02-04 1993-12-21 Piljac Goran & Piljac Visnja Farmaceutisch preparaat op basis van rhamnolipide.
US5409703A (en) * 1993-06-24 1995-04-25 Carrington Laboratories, Inc. Dried hydrogel from hydrophilic-hygroscopic polymer
DK1056462T3 (da) 1998-02-24 2007-12-03 Paradigm Biomedical Inc Anvendelse af rhamnolipider som kosmetiske midler

Also Published As

Publication number Publication date
EP1200100B1 (de) 2010-07-14
WO2001010447A1 (en) 2001-02-15
CA2378557C (en) 2009-12-08
US7129218B2 (en) 2006-10-31
US20040224905A1 (en) 2004-11-11
ATE473749T1 (de) 2010-07-15
EP1200100A1 (de) 2002-05-02
EP1200100A4 (de) 2004-05-19
CA2378557A1 (en) 2001-02-15
AU6489300A (en) 2001-03-05

Similar Documents

Publication Publication Date Title
DE60044674D1 (de) Verwendung von rhamnolipiden zur wundheilung, behaund periodontaler regeneration
DE50206297D1 (de) Arzneimittel auf Basis von Gestagenen zur dermalen Anwendung enthaltend Ascorbinsäure sowie deren Salze
ATE207342T1 (de) Gegen hautalterung wirksame stoffe oder wirkstoffkombinationen und zubereitungen
DE59712501D1 (de) 1-benzyl-3-(substituiertes-hetaryl)-kondensierten pyrazol-derivaten zur behandlung von erkrankungen des herz-kreislaufsystems und des zentralnervensystems
DE69937562D1 (de) Verbessertes angereichertes blutplättchen wundheilmittel
BRPI9908182C1 (pt) composições de proteína de matriz para cura de feridas
ATE269089T1 (de) Verwendung von vitamin d derivaten zur verstärkung der wirkung von zytotoxischen stoffen
DE59911740D1 (de) Topisch anwendbare mittel gegen nagelpilzerkrankungen
SE9701162D0 (sv) New use II
AU2001296865A1 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
EP2767291A3 (de) Behandlung der Glykogenspeicherkrankheit Typ II
ATE452640T1 (de) Mittel für erkrankungen assoziert mit knochensubstanzverlust
AU2740797A (en) Androstene derivatives
AU3850600A (en) Dalda analogs and their use
WO1999043344A3 (en) Matrix protein compositions for wound healing
ATE243196T1 (de) Piperidine und pyrrolidine
PT1089704E (pt) Locao tricologica para aplicacao topica
DE69814394D1 (de) Verwendung von levobupivacain
ATE368455T1 (de) Verwendung von (+)-tramadol, o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz
DK0888327T3 (da) Benzopyranderivater, som har antagonistisk virkning imod leukotriener
ATE390124T1 (de) Behandlung von mastitis mit einer kombination aus prednisolon und cephalosporin
ATE344662T1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
WO2001070184A3 (en) A composition containing monoterpenes for topical oral administration
WO2002051404A8 (fr) Compositions orales
NO20001846L (no) Nye farmasøytisk aktive forbindelser, deres fremstilling og anvendelse som ECE-inhibitorer